<DOC>
	<DOCNO>NCT01848743</DOCNO>
	<brief_summary>In Taiwan , 15 % general population hepatitis B virus ( HBV ) infection , HBV lead cause liver cirrhosis hepatocellular carcinoma Taiwan . After enter immune clearance , 10-30 % patient chronic HBV develop acute exacerbation ( AE ) , mild develop hepatic decompensation even death . Previous study find early use lamivudine bilirubin level 20 mg/dl improve survival chornic HBV severe AE . From study Hongkong , lamivudine find good survival entecavir chronic HBV severe AE . Recent study India find tenofovir able improve survival chronic HBV severe AE . The aim study compare effect lamivudine tenofovir chronic HBV severe AE . The study aim enroll 120 patient chronic HBV define persistence HBsAg 6 month . Severe AE define ALT &gt; 400 U/L , prolongation prothrombin time &gt; 3 second , bilirubin &gt; 2 mg/dl . Patients hepatitis A , C , D HIV infection , drug alcoholic liver disease , hepatocellular carcinoma , immuno-suppressive agent use , previous use anti-HBV agent exclude . All enrol patient randomize group A receive tenofovir 300 mg qd 3 year group B receive lamivuidne 100 mg qd 6 month , follow tenofovir 300mg qd 30 month . Mortality rate virological , biochemical serological response evaluate 1,2,4,48,96 144 week . The value express mean + SD . Categorical variable analyze Chi-square test Fisher 's exact test appropriate continuous variable analyze Mann-Whitney test . Logistic regression test apply analyze independent association various variable outcome . A p value &lt; 0.05 regarded significant .</brief_summary>
	<brief_title>Tenofovir Versus Lamivudine Patients Chronic Hepatitis B With Severe Acute Exacerbation</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HBsAg ( + ) &gt; 6 month ALT &gt; 5X ULN Prolongation prothrombin time &gt; 3 second bilirubin level &gt; 2 mg/dl 2075 year old HAV , HCV , HDV HIV coinfection Concurrent hepatocellular carcinoma Drug , metabolic alcohol cause hepatitis Antiviral treatment recent 6 mnths Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>tenofovir , lamivudine , hepatitis B , acute exacerbation</keyword>
</DOC>